Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor

Coadministration of Dabigatran Etexilate and Atorvastatin

(2013) Joachim Stangier et al.   American Journal of Cardiovascular Drugs

Dabigatran Etexilate for the Prophylaxis of Venous Thromboembolism After Hip or Knee Replacement Rationale for Dose Regimen

(2009) Ola E. Dahl   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Dabigatran Etexilate: Future Directions in Anticoagulant Treatment

(2009) Sam Schulman et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Dabigatran Etexilate: Pivotal Trials for Venous Thromboembolism Prophylaxis After Hip or Knee Arthroplasty

(2009) Bengt I. Eriksson et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects

(2009) Joachim Stangier et al.   CLINICAL PHARMACOKINETICS

Parenteral Anticoagulants

(2008) Jack Hirsh et al.   CHEST

Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate

(2008) Joachim Stangier   CLINICAL PHARMACOKINETICS

Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

(2008)   JOURNAL OF ARTHROPLASTY

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment

(2008) Joachim Stangier et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Triggers, targets and treatments for thrombosis

(2008) Nigel Mackman   NATURE